Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Myomo Inc. Common Stock (NY: MYO )

6.120 +0.030 (+0.49%)
Official Closing Price Updated: 8:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Myomo Inc. Common Stock

< Previous 1 2 3 4 5 6 Next >
Top 3 Cutting-Edge Micro-Caps Set for 2025 Growth
These three high-tech micro-cap stocks have made solid business progress in 2024, warranting them to be on investors radars in 2025. 
Via MarketBeat
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Myomo, Inc. Prices $15.0 Million Public Offering of Common Stock
From Myomo, Inc.
Via Business Wire
Myomo, Inc. Announces Proposed Public Offering of Common Stock
From Myomo, Inc.
Via Business Wire
The Analyst Verdict: Myomo In The Eyes Of 4 Experts
Via Benzinga
Recap: Myomo Q4 Earnings
Via Benzinga
Nvidia To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Myomo Reports Record Third Quarter Financial and Operating Results
From Myomo, Inc.
Via Business Wire
Myomo Announces First Private Payer Contracts for MyoPro In-network Coverage
From Myomo, Inc.
Via Business Wire
Myomo to Report Third Quarter Financial Results on November 6, 2024
From Myomo, Inc.
Via Business Wire
Myomo to Participate in the 2024 Maxim Healthcare Virtual Summit
From Myomo, Inc.
Via Business Wire
Myomo, Inc. Announces the Launch of Myomo Academy at AOPA National Assembly
From Myomo, Inc.
Via Business Wire
Myomo to Participate in Two Investor Conferences in September
From Myomo, Inc.
Via Business Wire
Myomo Reports Second Quarter 2024 Financial Results
From Myomo, Inc.
Via Business Wire
Myomo to Report Second Quarter Financial Results on August 6, 2024
From Myomo, Inc.
Via Business Wire
The 3 Best Robotic Exoskeleton Stocks to Buy Now
The best Robotic Exoskeletons stocks are highly lucrative, given recent industry developments and growing product uptake. 
Via InvestorPlace
Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Gold Falls Over 1%; HilleVax Shares Plunge
Via Benzinga
Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Dow Turns Lower; Myomo Shares Jump
Via Benzinga
Topics Stocks
Exposures US Equities
Myomo Reports Preliminary Second Quarter 2024 Revenues and Operating Metrics
From Myomo, Inc.
Via Business Wire
Sidoti Events, LLC's Virtual June Small-Cap Conference
Via ACCESSWIRE
Myomo to Present at the Sidoti Virtual Investor Conference on June 12-13, 2024
From Myomo, Inc.
Via Business Wire
MYO Stock Earnings: Myomo Meets EPS, Misses Revenue for Q1 2024
MYO stock results show that Myomo met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Myomo Reports First Quarter 2024 Financial Results
From Myomo, Inc.
Via Business Wire
Myomo Announces First Lump Sum Reimbursements for MyoPros Delivered to Medicare Part B Beneficiaries Under New CMS Fees
From Myomo, Inc.
Via Business Wire
Myomo to Report First Quarter Financial Results on May 8, 2024
From Myomo, Inc.
Via Business Wire
Myomo Appoints Heather Getz to its Board of Directors
From Myomo, Inc.
Via Business Wire
MYO Stock Earnings: Myomo Misses EPS, Misses Revenue for Q4 2023
MYO stock results show that Myomo missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.